<DOC>
	<DOCNO>NCT01624870</DOCNO>
	<brief_summary>The CoreValve ADVANCE-II Study best practice investigation patient implant Medtronic CoreValve bioprosthesis .</brief_summary>
	<brief_title>CoreValve Advance-II Study : Prospective International Post-market Study</brief_title>
	<detailed_description>The CoreValve ADVANCE-II Study best practice investigation patient implant Medtronic CoreValve bioprosthesis . The purpose study characterize best practice CoreValve implantation effort evolve implantation guideline .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Fulfilling criterion label indication CoreValve System ; Patient minimum age require local regulation participate clinical trial regardless gender race ; Provided Signed Informed Consent Data Release Form . Patients device regulate heart rhythm pacing ( e.g . pacemaker , resynchronization device , implanted defibrillator ) ; Patients preexist class I class II indication new pacemaker implantation accord 2007 ESC guideline ; Persistent permanent atrial fibrillation ( except paroxysmal AF ) ; Participation another drug device study would jeopardize appropriate analysis endpoint study . High probability nonadherence followup requirement ( due social , psychological medical reason ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Aortic Valve Stenonis</keyword>
	<keyword>Valvular Heart Disease</keyword>
	<keyword>Transcatheter Aortic Valve Implantation</keyword>
</DOC>